Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 626

1.
3.

Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women.

De Bacquer D, De Backer G, Kornitzer M, Myny K, Doyen Z, Blackburn H.

J Am Coll Cardiol. 1998 Sep;32(3):680-5.

4.

Impact of minor electrocardiographic ST-segment and/or T-wave abnormalities on cardiovascular mortality during long-term follow-up.

Greenland P, Xie X, Liu K, Colangelo L, Liao Y, Daviglus ML, Agulnek AN, Stamler J.

Am J Cardiol. 2003 May 1;91(9):1068-74.

PMID:
12714148
5.

The predictive value of electrocardiographic abnormalities for total and cardiovascular disease mortality in men and women.

De Bacquer D, Martins Pereira LS, De Backer G, De Henauw S, Kornitzer M.

Eur Heart J. 1994 Dec;15(12):1604-10.

PMID:
7698128
6.
7.

Computerized ST depression analysis improves prediction of all-cause and cardiovascular mortality: the strong heart study.

Okin PM, Devereux RB, Kors JA, van Herpen G, Crow RS, Fabsitz RR, Howard BV.

Ann Noninvasive Electrocardiol. 2001 Apr;6(2):107-16.

PMID:
11333167
8.

Prevalences of ECG findings in large population based samples of men and women.

De Bacquer D, De Backer G, Kornitzer M.

Heart. 2000 Dec;84(6):625-33.

9.

Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men.

Lowe LP, Greenland P, Ruth KJ, Dyer AR, Stamler R, Stamler J.

Arch Intern Med. 1998 Oct 12;158(18):2007-14.

PMID:
9778200
10.

Electrocardiographic findings and incident coronary heart disease among participants in the Atherosclerosis Risk in Communities (ARIC) study.

Machado DB, Crow RS, Boland LL, Hannan PJ, Taylor HA Jr, Folsom AR.

Am J Cardiol. 2006 Apr 15;97(8):1176-1181.

PMID:
16616022
11.

Prognostic value of ST-T abnormalities and left high R waves with cardiovascular mortality in Japanese (24-year follow-up of NIPPON DATA80).

Rumana N, Turin TC, Miura K, Nakamura Y, Kita Y, Hayakawa T, Choudhury SR, Kadota A, Nagasawa SY, Fujioshi A, Takashima N, Okamura T, Okayama A, Ueshima H; NIPPON DATA80 Research Group..

Am J Cardiol. 2011 Jun 15;107(12):1718-24. doi: 10.1016/j.amjcard.2011.02.335.

PMID:
21497783
12.

Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study.

Sempos CT, Looker AC, Gillum RE, McGee DL, Vuong CV, Johnson CL.

Ann Epidemiol. 2000 Oct;10(7):441-8.

PMID:
11023623
13.

Major and minor electrocardiographic abnormalities and risk of death from coronary heart disease, cardiovascular diseases and all causes in men and women.

Liao YL, Liu KA, Dyer A, Schoenberger JA, Shekelle RB, Colette P, Stamler J.

J Am Coll Cardiol. 1988 Dec;12(6):1494-500.

PMID:
3192848
14.

Prevalences and association of ECG findings and cardiovascular risk factor in Shinawatra employees.

Sriratanaviriyakul N, Kangkagate C, Krittayaphong R.

J Med Assoc Thai. 2010 Jan;93 Suppl 1:S1-10.

PMID:
20364551
15.

Prognostic value of the computerized ECG in Hispanics.

Perez MV, Yaw TS, Myers J, Froelicher VF.

Clin Cardiol. 2007 Apr;30(4):189-94.

16.

The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience.

Reunanen A, Aromaa A, Pyörälä K, Punsar S, Maatela J, Knekt P.

Acta Med Scand Suppl. 1983;673:1-120.

PMID:
6578675
17.

Electrocardiographic abnormalities predict deaths from cardiovascular disease and ischemic heart disease in Pima Indians with type 2 diabetes.

Jimenez-Corona A, Nelson RG, Sievers ML, Knowler WC, Hanson RL, Bennett PH.

Am Heart J. 2006 May;151(5):1080-6.

PMID:
16644339
18.

Prognostic value of heart rate adjustment of exercise-induced ST segment depression in the multiple risk factor intervention trial.

Okin PM, Grandits G, Rautaharju PM, Prineas RJ, Cohen JD, Crow RS, Kligfield P.

J Am Coll Cardiol. 1996 May;27(6):1437-43.

19.

Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).

Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB; LIFE Study Investigators..

Circulation. 2009 Apr 14;119(14):1883-91. doi: 10.1161/CIRCULATIONAHA.108.812313.

20.

Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy.

Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB.

Circulation. 1994 Oct;90(4):1786-93.

PMID:
7923663
Items per page

Supplemental Content

Support Center